Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

Ryoncil

Drug Steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients

NDC 73648-111-01

Open in the dashboard

General payments

$559,842

207 payments

Research payments

$0

0 payments

Through program year 2025, $559,842 in general payments and $0 in research payments were reported against Ryoncil (Steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $559,842 207

Breakdown

Who paid General payments · program year 2025
  1. Mesoblast, Inc. $559,842 207 payments
Top recipients General payments · program year 2025
  1. Philip Krause Infectious Disease · Potomac, MD $346,381 62% · 17 payments
  2. Jie Cheng Clinical Cardiac Electrophysiology · Houston, TX $60,511 11% · 8 payments
  3. Joanne Kurtzberg Pediatric Hematology-Oncology · Durham, NC $28,218 5% · 3 payments
  4. Michael Rosen Pediatric Gastroenterology · Palo Alto, CA $15,200 3% · 4 payments
  5. John Levine Pediatric Hematology-Oncology · New York, NY $11,868 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Infectious Disease Internal Medicine $346,381 62% · 1 practitioner
  2. Pediatric Hematology-Oncology Pediatrics $119,279 21% · 71 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $60,511 11% · 1 practitioner
  4. Pediatric Gastroenterology Pediatrics $15,200 3% · 1 practitioner
  5. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $3,530 <1% · 3 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $346,558 62% · 2 recipients
  2. Texas $67,354 12% · 15 recipients
  3. New York $31,712 6% · 11 recipients
  4. California $30,155 5% · 29 recipients
  5. North Carolina $28,647 5% · 3 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

207 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record